PDF) WTX101 in patients newly diagnosed with Wilson disease: final

Inorganics, Free Full-Text

Exploring the potential of trientine tetrahydrochloride in the treatment of Wilson disease - ScienceDirect

Aftab ALA, Professor, MBBS MD PhD FRCP, University of Surrey, Guildford, School of Biosciences and Medicine & Department of Health Management and Strategy

Update on the Diagnosis and Management of Wilson Disease

PDF) Edging closer to successful gene therapy for Wilson disease

PDF) Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent

Wilson Disease - Practical Neurology

Diagnosis - Wilson Disease Association

PDF) Wilson's Disease: An Update on the Diagnostic Workup and Management

IJMS, Free Full-Text

Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent

Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. - Abstract - Europe PMC

PDF) WTX101 in patients newly diagnosed with Wilson disease: final results of a global, prospective phase 2 trial

Exploring the potential of trientine tetrahydrochloride in the treatment of Wilson disease - ScienceDirect

Cureus, Demographics and Outcomes Related to Wilson's Disease Patients: A Nationwide Inpatient Cohort Study